Apnea of prematurity pharmacotherapy

U.S. Pharmacist

Volumn 35, Issue 3, 2010, Pages

  Siu, Anita ^a   James, Anitha ^b  

^a RUTGERS UNIVERSITY   (United States)

^b University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CARNITINE; CREATINE; CYCLIC AMP; CYCLIC GMP; CYTOCHROME P450 1A2; DOXAPRAM; METHYLXANTHINE DERIVATIVE; PARAXANTHINE; THEOBROMINE; THEOPHYLLINE;

ABDOMINAL PAIN; BRAIN BLOOD FLOW; CLINICAL FEATURE; CONTINUOUS INFUSION; DIARRHEA; DIURESIS; DRUG CLEARANCE; DRUG HALF LIFE; DRUG MONITORING; DRUG SAFETY; FEEDING DISORDER; GASTROESOPHAGEAL REFLUX; HEART ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; IRRITABILITY; NEWBORN; NEWBORN APNEA; PATHOPHYSIOLOGY; QT PROLONGATION; RECOMMENDED DRUG DOSE; REVIEW; SECOND DEGREE ATRIOVENTRICULAR BLOCK; SEIZURE; SIDE EFFECT; TACHYCARDIA; TREATMENT PLANNING; VOMITING;

EID: 77954618779     PISSN: 01484818     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Review

References (35)

1. Taeusch HW, Ballard RA, Gleason CA. Avery's Diseases of the Newborn. 8th ed. Philadelphia, PA: Elsevier, Inc.; 2005:619-620.
2. Anas NG, Perkin RM. The pathophysiology of apnea of infancy. Perinatal-Neonatal. 1984;8:58-70.
3. Martin RJ, Fanaroff AA, Walsh MC. Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant. Philadelphia, PA: Mosby Elsevier; 2006:1135-1141.
4. Martin RJ, Miller MJ, Carlo WA. Pathogenesis of apnea in preterm infants. J Pediatr. 1986;109:733-741.
5. Wilson CG, Martin RJ, Jaber M, et al. Adenosine A2A receptors interact with GABAergic pathways to modulate respiration in neonatal piglets. Respir Physiol Neurobiol. 2004;14:201-211. (Pubitemid 38887257)
6. Herlenius E, Lagercrantz H. Adenosinergic modulation of respiratory neurones in the neonatal rat brainstem in vitro. J Physiol. 1999;518:159-172. (Pubitemid 29332961)
7. McIntosh-Yellin NL, Drew BJ, Scheinman MM. Safety and efficacy of central intravenous bolus administration of adenosine for termination of supraventricular tachycardia. J Am Coll Cardiol. 1993;22:741-745.
8. Corvaglia L, Zama D, Gualdi S, et al. Gastro-oesophageal reflux increases the number of apneoas in very preterm infants. Arch Dis Child Fetal Neonatal Ed. 2009;94:188-192.
9. Krauss AN. Apnea in infancy: pathophysiology, diagnosis, and treatment. NY State J Med. 1986;86:89-96. (Pubitemid 16144958)
10. Henderson-Smart DJ. The effect of gestational age on the incidence and duration of recurrent apneoa in newborn babies. Aust Paediatr J. 1981;17:273-276.
11. Eichenwald EC, Aina A, Stark A. Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks. Pediatrics. 1997;100:354-359. (Pubitemid 27377000)
12. Cheung PY, Barrington KJ, Finer NN, Robertson CM. Early childhood neurodevelopment in very low birth weight infants with pre-discharge apnea. Pediatr Pulmonol. 1999;27:14-20.
13. Jones RA, Lukeman D. Apnoea of immaturity. 2. Mortality and handicap. Arch Dis Child. 1982;57:766-768.
14. Grisemer AN. Apnea of prematurity; current management and nursing implications. Pediatr Nurs. 1990;16:606-611.
15. Bhatia J. Current options in the management of apnea of prematurity. Clin Pediatr (Phila). 2000;39:327-336.
16. Gayan-Ramirez G, Janssens S, Himpens B, Decramer M. Mechanism of theophylline-induced inotropic effects on foreshortened canine diaphragm. Eur Respir J. 1995;8:1915-1921.
17. Polson JB, Krzanowski JJ, Goldman AL, Szentivanyi A. Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline. Clin Exp Pharmacol Physiol. 1978;5:535-539. (Pubitemid 9032770)
18. Aubier M, Murciano D, Viires N, et al. Diaphragmatic contractility enhanced by aminophylline: role of extracellular calcium. J Appl Physiol. 1983;54:460-464.
19. Davis JM, Spitzer AR, Stefano JL, et al. Use of caffeine in infants unresponsive to theophylline in apnea of prematurity. Pediatr Pulmonol. 1987;3:90-93.
20. Hendeles L, Jenkins J, Temple R. Revised FDA labeling guideline for theophylline oral dosage forms. Pharmacotherapy. 1995;15:409-427.
21. Erenberg A, Leff RD, Haack DG, et al. Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study. Pharmacotherapy. 2000;20:644-652. (Pubitemid 30387680)
22. Natarajan G, Botica ML, Thomas R, Aranda JV. Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise? Pediatrics. 2007;119:936-940.
23. Bhatt-Mehta V, Schumacher RE. Treatment of apnea of prematurity. Pediatr Drugs. 2003;5:195-210.
24. Aranda JV, Cook CE, Gorman W, et al. Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J Pediatr. 1079;94:663-668.
25. Davis PG, Doyle LW, Rickards AL, et al. Methylxanthines and sensorineural outcome at 14 years in children < 1501 g birth weight. J Paediatr Child Health. 2000;36:47-50. (Pubitemid 30126214)
26. Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;257:1893-1902. (Pubitemid 350074685)
27. Brouard C, Moriette D, Murat I, et al. Comparative efficacy of theophylline and caffeine in the treatment of idiopathic apnea of premature infants. Am J Dis Child. 1985;139:698-700. (Pubitemid 15006408)
28. Bairam A, Boutroy MJ, Badonnel Y, et al. Theophylline versus caffeine: comparative effects in the treatment of idiopathic apnea in the preterm infant. J Pediatr. 1987;110:636-638.
29. Scanlon JE, Chin KC, Morgan ME, et al. Caffeine or theophylline for neonatal apnea? Arch J Dis Child. 1992;67:425-428.
30. Larsen PB, Brendstrup, Skov L, Fachs L. Aminophylline versus caffeine citrate for apnea and bradycardia prophylaxis in premature neonates. Acta Paediatr. 1995;84:360-364.
31. Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook. 16th ed. Houston, TX: Lexi-Comp Inc; 2009.
32. Edwards G, Lond MB, Leszczynski SO. A double-blind trial of five respiratory stimulants in patients with acute ventilatory failure. Lancet. 1967;290:226-229.
33. O'Donnell J, Finer NN, Rich W, et al. Role of L-carnitine in apnea of prematurity: a randomized, controlled trial. Pediatrics. 2002;109:622-626. (Pubitemid 34286295)
34. Kumar M, Kabra NS, Paes B. Carnitine supplementation for preterm infants with recurrent apnea. Cochrane Database Syst Rev. 2004;(4):CD004497.
35. Bohnhorst B, Geuting T, Peter CS, et al. Randomized, controlled trial of oral creatine supplementation (not effective) for apnea of prematurity. Pediatrics. 2004;113:e303-e307.